Internal Medicine · National City, CA
NPI
1245322213
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2340 E 8th St, Suite J
National City, CA, 91950
Phone (619) 479-0320
Groups this clinician bills Medicare through
Medicare paid, 2024
$140K
1,533 services
Medicare patients, 2024
334
Average age 77
Drug cost, 2024
$1.6M
10,778 prescriptions
Company payments, 2025
$2,153
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irineo D Tiangco was code 99214 (office e&m - established), 755 times for 312 patients. In total Irineo D Tiangco billed 1,533 services in 19 codes, and Medicare paid $140K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 755 | 312 | $102.74 | $78K |
| 99213 Office E&M - Established | Office | 225 | 153 | $73.21 | $16K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 203 | 203 | $138.80 | $28K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 151 | 151 | $20.88 | $3,153 |
| 93000 Electrocardiogram | Office | 50 | 43 | $12.01 | $600 |
| 96372 Injection Administration | Office | 23 | 16 | $12.44 | $286 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 23 | 23 | $175.09 | $4,027 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 19 | 16 | $240.05 | $4,561 |
| 99204 Office E&M - New | Office | 16 | 16 | $121.58 | $1,945 |
| 82962 Clinical Chemistry | Office | 12 | 11 | $3.21 | $38.52 |
By year: 2022 $134K for 1,571 services; 2023 $147K for 1,620 services; 2024 $140K for 1,533 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 12 | 11 | $3.21 | $38.52 |
Medicare prescription drug claims, 2024
In 2024, the drug Irineo D Tiangco prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,023 prescriptions and refills. In total Irineo D Tiangco wrote 10,778 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,023 | 2,966 | 285 | $20K |
| Amlodipine Besylate Generic | 596 | 1,741 | 179 | $4,758 |
| Atorvastatin Calcium Generic | 552 | 1,605 | 163 | $6,732 |
| Losartan Potassium Generic | 472 | 1,387 | 135 | $5,570 |
| Jardiance Empagliflozin | 397 | 687 | 88 | $370K |
| Metformin Hcl Generic | 382 | 1,081 | 108 | $3,511 |
| Carvedilol Generic | 316 | 898 | 92 | $3,604 |
| Alendronate Sodium Generic | 276 | 763 | 76 | $2,882 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 234 | 292 | 54 | $174K |
| Levocetirizine Dihydrochloride Generic | 227 | 639 | 76 | $2,714 |
| Metoprolol Succinate Generic | 222 | 646 | 68 | $3,005 |
| Acarbose Generic | 211 | 513 | 52 | $12K |
| Raloxifene Hcl Generic | 190 | 549 | 59 | $5,827 |
| Tamsulosin Hcl Generic | 171 | 487 | 52 | $2,976 |
| Farxiga Dapagliflozin Propanediol | 169 | 295 | 41 | $156K |
Brand drugs: 1,954 claims; generic drugs: 8,646 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Irineo D Tiangco $2,153 ($2,153 in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $540.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 7 | $540 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $499 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $368 |
| Lilly USA, LLC LLY | 6 | $255 |
| GlaxoSmithKline, LLC. GSK | 6 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $125 |
| Abbvie Inc. ABBV | 5 | $96.11 |
| Novo Nordisk Inc NVO | 1 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $44.05 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $30.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.